Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270
- PMID: 20079562
- DOI: 10.1016/j.vaccine.2009.02.078
Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270
Abstract
In this study, a new subunit vaccine that comprised native F1 and recombinant rV270 was evaluated for protective efficacy using mouse, guinea pig and rabbit models in comparison with the live attenuated vaccine EV76. Complete protection against challenging with 10(6) colony-forming units (CFU) of virulent Yersinia pestis strain 141 was observed for mice immunized with the subunit vaccines and EV76 vaccine. In contrast, the subunit vaccine recipes VII (F1-20 microg+rV270-10 microg) and IX (F1-40 microg+rV270-20 microg) and EV76 vaccine provided 86%, 79% and 93% protection against the same level of challenge in guinea pigs and 100%, 83% and 100% protection in rabbits, respectively. The immunized mice with the vaccines had significantly higher IgG titres than the guinea pigs and rabbits, and the immunized guinea pigs developed significantly higher IgG titres than the rabbits, but the anti-F1 response in guinea pigs was more variable than in the mice and rabbits, indicating that guinea pig is not an ideal model for evaluating protective efficacy of plague subunit vaccine, instead the rabbits could be used as an alternative model. All the immunized animals with EV76 developed a negligible IgG titre to rV270 antigen. Furthermore, analysis of IgG subclasses in the immunized animals showed a strong response for IgG1, whereas those receiving EV76 immunization demonstrated predominant production of IgG1 and IgG2a isotypes. The subunit vaccine and EV76 vaccine are able to provide protection for animals against Y. pestis challenge, but the subunit vaccines have obvious advantages over EV76 in terms of safety of use.
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
[Evaluation of immunization protection efficacy of plague subunit vaccine].Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Sep;43(9):785-8. Zhonghua Yu Fang Yi Xue Za Zhi. 2009. PMID: 20137561 Chinese.
-
Comparison of immunological responses of plague vaccines F1+rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta.Scand J Immunol. 2010 Nov;72(5):425-33. doi: 10.1111/j.1365-3083.2010.02456.x. Scand J Immunol. 2010. PMID: 21039737
-
Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.Microb Pathog. 1997 Sep;23(3):167-79. doi: 10.1006/mpat.1997.0141. Microb Pathog. 1997. PMID: 9281474
-
Prospects for new plague vaccines.Expert Rev Vaccines. 2009 Dec;8(12):1721-38. doi: 10.1586/erv.09.129. Expert Rev Vaccines. 2009. PMID: 19943765 Review.
-
Kinetics of memory B cell and plasma cell responses in the mice immunized with plague vaccines.Scand J Immunol. 2014 Mar;79(3):157-62. doi: 10.1111/sji.12146. Scand J Immunol. 2014. PMID: 24383627 Review.
Cited by
-
Humoral and cellular immune response of mice challenged with Yersinia pestis antigenic preparations.Braz J Infect Dis. 2017 Nov-Dec;21(6):620-626. doi: 10.1016/j.bjid.2017.09.001. Epub 2017 Oct 12. Braz J Infect Dis. 2017. PMID: 29031042 Free PMC article.
-
Long-term observation of subunit vaccine F1-rV270 against Yersinia pestis in mice.Clin Vaccine Immunol. 2010 Jan;17(1):199-201. doi: 10.1128/CVI.00305-09. Epub 2009 Nov 25. Clin Vaccine Immunol. 2010. PMID: 19940042 Free PMC article.
-
Protocol for recombinant RBD-based SARS vaccines: protein preparation, animal vaccination and neutralization detection.J Vis Exp. 2011 May 2;(51):2444. doi: 10.3791/2444. J Vis Exp. 2011. PMID: 21587153 Free PMC article.
-
Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.Hum Vaccin Immunother. 2014;10(2):368-77. doi: 10.4161/hv.27060. Epub 2013 Nov 13. Hum Vaccin Immunother. 2014. PMID: 24225642 Free PMC article.
-
Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation.Front Immunol. 2022 Jan 26;13:793382. doi: 10.3389/fimmu.2022.793382. eCollection 2022. Front Immunol. 2022. PMID: 35154110 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical